Duraclon Clonidine HCl Injection 100 mcg / mL Preservative Free 10 mL (RX)

Duraclon (Clonidine HCl Injection) 100 mcg is used primarily for the management of severe pain in cancer patients. Administered epidurally, it acts as an adjunct to opioid therapy, enhancing pain relief while potentially reducing the necessary dosage of opioids. Clonidine works by activating alpha-2 adrenergic receptors, which helps modulate the perception of pain. It is used in clinical settings under careful medical supervision to ensure effective pain management and monitor side effects.

Discover the targeted efficacy of Duraclon, a clonidine hydrochloride injection designed for precise management of severe pain in cancer patients who do not respond adequately to opioid therapy alone. Duraclon offers healthcare professionals a supplementary tool, designed for epidural infusion, providing pain relief with a unique pharmacological profile that augments analgesia.

Product Details and Features

Product Name: Duraclon (Clonidine Hydrochloride) Injection
Concentration: 100 mcg/mL
Manufacturer: Mylan Institutional
Dosage Form: Sterile liquid for epidural infusion
Packaging: Provided in securely sealed vials, ensuring sterility and integrity
Indications: Specifically tailored as an adjuvant for the treatment of severe pain in cancer patients, in combination with opioids.
Storage Conditions: Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Protect from light to maintain efficacy.

Features

Enhanced Pain Management: Acts as a potent adjuvant to heighten the analgesic effects of opioids.
Epidural Delivery: Direct, local administration improves the targeted action to optimize patient comfort.
Quality Manufacture: Produced by Mylan Institutional, assuring consistency, safety, and reliability.

Mechanism of Action

Duraclon contains clonidine, an alpha-2 adrenergic agonist. It works primarily through the stimulation of alpha-2 receptors in the dorsal horn of the spinal cord, which reduces the sympathetic outflow, resulting in decreased nociceptive neurotransmitter release and hyperpolarization of pain-conducting neurons. This modulation of pain signals provides effective analgesic properties when used epidurally, especially when synergistically combined with opioids.

Directions for Use

1. Administration Method: Intended strictly for epidural infusion. Ensure proper aseptic technique during handling.
2. Dilution and Dosage: Dilute with an appropriate epidural infusion solution to achieve a dose-specific combination, as per the detailed instruction of the healthcare provider. Usually administered at a rate specific to patient needs, often requiring careful titration.
3. Monitoring: Close monitoring of the patient's blood pressure and other vitals is essential during administration.

Warnings

• Appropriate Use: Not recommended for obstetrical, postpartum, or perioperative pain management due to potential hypotension and bradycardia risks.
  
• Hemodynamic Stability: May cause significant hypotension; therefore, use with intense caution in patients with severe cardiovascular disorders.
  
• CNS Depressants: Coadministration with CNS depressants requires cautious titration and monitoring due to potential potentiation of effects.
  
• Withdrawal Concerns: Abrupt discontinuation may induce rebound hypertension; discontinue therapy under medical supervision.

Side Effects

While Duraclon is generally well-managed under medical supervision, potential side effects include:

• Cardiovascular: Hypotension, bradycardia, and possible orthostatic events.
  
• Central Nervous: Sedation, dizziness, headache, dry mouth.
  
• Injection Site Reactions: Potential localized reactions due to epidural administration.

Each patient's response can differ; hence, healthcare providers should tailor treatment plans with these considerations in mind. The intent is always to balance effective pain management with minimizing adverse effects.

Using Duraclon (Clonidine HCl) Injection from Mylan Institutional can play a crucial role in providing comprehensive, effective pain relief for eligible patients, enhancing quality of life and patient care outcomes.